Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Medicina (Kaunas) ; 60(6)2024 May 26.
Artículo en Inglés | MEDLINE | ID: mdl-38929485

RESUMEN

Uterine fibroids (leiomyomas and myomas) are the most common benign gynecological condition in patients presenting with abnormal uterine bleeding, pelvic masses causing pressure or pain, infertility and obstetric complications. Almost a third of women with fibroids need treatment due to symptoms. OBJECTIVES: In this review we present all currently available treatment modalities for uterine fibroids. METHODS: An extensive search for the available data regarding surgical, medical and other treatment options for uterine fibroids was conducted. REVIEW: Nowadays, treatment for fibroids is intended to control symptoms while preserving future fertility. The choice of treatment depends on the patient's age and fertility and the number, size and location of the fibroids. Current management strategies mainly involve surgical interventions (hysterectomy and myomectomy hysteroscopy, laparoscopy or laparotomy). Other surgical and non-surgical minimally invasive techniques include interventions performed under radiologic or ultrasound guidance (uterine artery embolization and occlusion, myolysis, magnetic resonance-guided focused ultrasound surgery, radiofrequency ablation of fibroids and endometrial ablation). Medical treatment options for fibroids are still restricted and available medications (progestogens, combined oral contraceptives andgonadotropin-releasing hormone agonists and antagonists) are generally used for short-term treatment of fibroid-induced bleeding. Recently, it was shown that SPRMs could be administered intermittently long-term with good results on bleeding and fibroid size reduction. Novel medical treatments are still under investigation but with promising results. CONCLUSIONS: Treatment of fibroids must be individualized based on the presence and severity of symptoms and the patient's desire for definitive treatment or fertility preservation.


Asunto(s)
Leiomioma , Humanos , Leiomioma/terapia , Leiomioma/cirugía , Femenino , Neoplasias Uterinas/terapia , Neoplasias Uterinas/cirugía , Neoplasias Uterinas/complicaciones , Histerectomía/métodos , Embolización de la Arteria Uterina/métodos , Miomectomía Uterina/métodos
2.
Medicina (Kaunas) ; 60(5)2024 May 17.
Artículo en Inglés | MEDLINE | ID: mdl-38793008

RESUMEN

Background and Objectives: Mutations in succinate dehydrogenase (SDH) and fumarate hydratase (FH) give rise to various familial cancer syndromes, with these alterations being characteristic of certain types of histomorphologically specific leiomyomas that hold significant predictive value. Materials and Methods: This study presents two cases of uterine leiomyomas exhibiting rare histomorphological and genetic characteristics, which are crucial for prognosis and further treatment. Results: Distinct histopathological features such as marked nuclear atypia, intracellular eosinophilic globules, and abnormal intratumoral vessels raise suspicion for specific leiomyoma subtypes, which carry predictive significance for additional hereditary cancer syndromes. Immunohistochemical analysis confirmed FH/SDH deficiency in both patients, who underwent careful follow-up. Conclusions: This study describes two cases involving unusual leiomyomas, the histopathological characteristics of which may easily go unrecognized. These features hold predictive significance because their specific mutations point to additional hereditary cancer syndromes, highlighting the need for further examinations.


Asunto(s)
Fumarato Hidratasa , Leiomioma , Succinato Deshidrogenasa , Neoplasias Uterinas , Humanos , Femenino , Fumarato Hidratasa/deficiencia , Fumarato Hidratasa/genética , Neoplasias Uterinas/genética , Neoplasias Uterinas/patología , Succinato Deshidrogenasa/deficiencia , Succinato Deshidrogenasa/genética , Adulto , Leiomioma/genética , Leiomioma/patología , Persona de Mediana Edad
3.
J Infect Dev Ctries ; 18(1): 60-65, 2024 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-38377086

RESUMEN

INTRODUCTION: Toxoplasma gondii is an obligate intracellular parasite affecting a broad range of warm-blooded animals, including humans. Infection acquired during pregnancy can be transmitted to the fetus and leading to serious problems such as spontaneous abortion, stillbirth, or severe mental and/or physical handicaps in the child. The purpose of this study was to investigate the seroprevalence of Toxoplasma infection and related risk factors in pregnant woman. METHODOLOGY: The study enrolled 1200 serum samples of pregnant women from February-November 2017. Then the samples were tested for the presence of anti-T. gondii antibodies (Ab) using enzyme-linked immunosorbent assay. RESULTS: Out of the 1200 samples, 381 (31.7%) and 41 (3.4%) subjects were positive for IgG and IgM Ab, respectively. Among the evaluated risk factors, the seroprevalence of Toxoplasma infection was not related to the occupation in a significant way. However significant relationship was observed with factors such as; contact with soil, cats, consumption of raw washed vegetables, and washed hands before meals. CONCLUSIONS: According to the results, more than two-thirds of pregnant women are susceptible to Toxoplasma infection, hence training health care programs should be provided to prevent infection.


Asunto(s)
Aborto Espontáneo , Toxoplasma , Toxoplasmosis , Animales , Niño , Humanos , Femenino , Embarazo , Mujeres Embarazadas , Estudios Seroepidemiológicos , Anticuerpos Antiprotozoarios , Inmunoglobulina G , Estudios Transversales , Toxoplasmosis/epidemiología , Factores de Riesgo , Inmunoglobulina M
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA